Positron emission tomography (PET) with fluorodeoxyglucose (FDG) has become an established imaging modality for evaluating patients with breast cancer. PET appears to be useful in that the metabolic aspect of PET imaging reflects the presence and extent of tumors usually more accurately and quickly than traditional anatomic imaging does. Recent advances in breast imaging with other modalities have also shown great promise. This basic to intermediate program discusses what breast cancer is and the procedure used for evaluating patients with this disease.
To find out if your facility has a subscription or to get information on how to become a subscriber, please contact us at email@example.com or call 1800 659 465.